MedTrace Logo

Hemodynamic Response After Six Months of Sildenafil

NCT00483626 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 27

Last updated 2007-06-07

No results posted yet for this study

Summary

The purpose of this study is to determine the clinical, functional and hemodynamic response after six months of sildenafil 50 mg TID in patients with pulmonary arterial hypertension.

Conditions

Interventions

DRUG

oral sildenafil

Sponsors & Collaborators

  • University of Chile

    lead OTHER

Principal Investigators

  • Monica M Zagolin, MD · National Institute of Thorax

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
16 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-08-31
Completion
2007-06-30

Countries

  • Chile

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00483626 on ClinicalTrials.gov